![]() |
![]() |
![]() |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
PSMX 424 - Pharmacotherapy of Addiction and Co-Existing Disorders
Convenor
EligibilityThis course is suitable for a range of senior practitioners working with people suffering addiction and co-existing mental health problems, including experienced case managers, general practitioners, practice nurses, pharmacists and opioid substitution treatment clinicians. All students will need to have a personal internet connection. ContentThis nationally accessible paper provides students with knowledge and clinical skills in the use of medications in the overall management and treatment of people with addiction and co-existing mental health disorders and medical problems. The treatment of opioid dependence is a prototype of drug-substitution therapy and is given some emphasis on this paper as it provides examples of the most complex cases in this area. The paper also deals with the range of new pharmacotherapies, both substitution and non-substitution treatments, that are becoming available in New Zealand. Teaching ArrangementsTwo compulsory two-day block courses plus active involvement in an email discussion group focused on 10 clinical cases (5 opioid / 5 non-opioid). The course starts in February with reading in preparation for the first block course. For Block Course dates, contact lindsay.atkins@otago.ac.nz Assessment
Enquiries to Prof Doug Sellman, National Addiction Centre, Department of Psychological Medicine, University of Otago, Christchurch, P O Box 4345, Christchurch, Tel (03) 364 0480, Fax (03) 364 1225, Email doug.sellman@otago.ac.nz website www.addiction.org.nz. Electronic addresses (including email accounts, instant messaging services, or telephone accounts) published on this page are for the sole purpose of contact with the individuals concerned, in their capacity as officers, employees or students of the University of Otago. Publication of any such electronic address is not to be taken as consent to receive unsolicited commercial electronic messages by the address holder.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||